Synonyms:
Status: Phase 2
Entry Type: Small molecule
Molecule Category: UNKNOWN
UNII: 0W79NDQ608

Structure

InChI Key FSWFYCYPTDLKON-CMJOXMDJSA-N
Smile C[C@@H]1CCC[C@H](n2cnc(-c3cc(Cl)ccc3-n3cc(Cl)nn3)cc2=O)c2cc(ccn2)-c2c(cnn2C(F)F)NC1=O
InChI
InChI=1S/C28H23Cl2F2N9O2/c1-15-3-2-4-23(20-9-16(7-8-33-20)26-21(36-27(15)43)12-35-41(26)28(31)32)39-14-34-19(11-25(39)42)18-10-17(29)5-6-22(18)40-13-24(30)37-38-40/h5-15,23,28H,2-4H2,1H3,(H,36,43)/t15-,23+/m1/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C28H23Cl2F2N9O2
Molecular Weight 626.46
AlogP 5.8
Hydrogen Bond Acceptor 10.0
Hydrogen Bond Donor 1.0
Number of Rotational Bond 4.0
Polar Surface Area 125.41
Molecular species NEUTRAL
Aromatic Rings 5.0
Heavy Atoms 43.0

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Coagulation factor XI inhibitor
Targets EC50(nM) IC50(nM) Kd(nM) Ki(nM) Inhibition(%)
Enzyme Hydrolase
- - - 35 -
Enzyme Protease Serine protease Serine protease PA clan Serine protease S1A subfamily
- - - 0.1-0.11 -

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Atrial Fibrillation 3 D001281 ClinicalTrials
Acute Coronary Syndrome 3 D054058 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4112929
DrugBank DB16233
FDA SRS 0W79NDQ608
PubChem 118277544
SureChEMBL SCHEMBL16982989